Buy this article for $7.95

Have a coupon or promotional code? Enter it here:

When you buy this article you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.

Source:

Cancer Nursing

December 2003, Volume 26 Number 6 , p 421 - 430

Authors

  • Maria de Carvalho MSN, RN, AOCN
  • Jean Jenkins PhD, RN, FAAN
  • Michele Nehrebecky MS, CRNP
  • Lynda Lahl MS, RN

Abstract

Persons undergoing genetic testing for an inherited predisposition to cancer often raise questions about recommendations for follow-up care. Missing from current guidelines is consideration of the role of estrogens for BRCA1/BRCA2 mutation carriers. Potential implications of hormones for risk of cancer and effectiveness of risk-reduction strategies need to be considered

To continue reading, buy this article for just $7.95.

Have a coupon or promotional code? Enter it here: